1-11 of 11
Hongwei Jiang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Meeting Abstracts

868-P: Efficacy and Safety of Crisugabalin with Acetyl-Levo-Carnitine in Chinese Patients with Diabetic Peripheral Neuropathic Pain—A Multicentre, Randomized, Open-Label, Positive-Controlled, Parallel-Group, Phase 2 Trial

HONGWEI JIANG, LIUJUN FU, NA XU, JUNJIE SHANG, QIUWEI YANG
Journal: Diabetes
Diabetes 2024;73(Supplement_1):868-P
https://doi.org/10.2337/db24-868-P
Published: 14 June 2024
View article titled, 868-P: Efficacy and Safety of Crisugabalin with Acetyl-Levo-Carnitine in Chinese Patients with Diabetic Peripheral Neuropathic Pain—A Multicentre, Randomized, Open-Label, Positive-Controlled, Parallel-Group, Phase 2 Trial
Meeting Abstracts

1857-LB: Improvement of Liver Steatosis by Mazdutide in Chinese Participants with Overweight or Obesity—An Exploratory Analysis of GLORY-1

LINONG JI, HONGWEI JIANG, YAWEI ZHANG, LINGCHUN LV, JIEYU GU, ZIHAN LIU, YANQI WANG, HUAN DENG, LEI QIAN
Journal: Diabetes
Diabetes 2024;73(Supplement_1):1857-LB
https://doi.org/10.2337/db24-1857-LB
Published: 14 June 2024
View article titled, 1857-LB: Improvement of Liver Steatosis by Mazdutide in Chinese Participants with Overweight or Obesity—An Exploratory Analysis of GLORY-1
Meeting Abstracts

1856-LB: Efficacy and Safety of Mazdutide in Chinese Participants with Overweight or Obesity (GLORY-1)

LINONG JI, HONGWEI JIANG, HUA LI, JUNHANG TIAN, DEXUE LIU, YUZHU ZHAO, JIEYU GU, ZIHAN LIU, HUAN DENG, YANQI WANG, LI LI, LEI QIAN, THE GLORY-1 INVESTIGATORS
Journal: Diabetes
Diabetes 2024;73(Supplement_1):1856-LB
https://doi.org/10.2337/db24-1856-LB
Published: 14 June 2024
View article titled, 1856-LB: Efficacy and Safety of Mazdutide in Chinese Participants with Overweight or Obesity (GLORY-1)
Meeting Abstracts

1866-LB: A Phase 2 Study of Mazdutide 9 mg in Chinese Adults with BMI of 30 kg/m2 or more

HONGWEI JIANG, LINONG JI, YAWEI ZHANG, ZHIFENG CHENG, SHUGUANG PANG, XIAOLI LI, WEI QIU, QINGYANG MA, ZIHAN LIU, YANQI WANG, HUAN DENG, LEI QIAN
Journal: Diabetes
Diabetes 2024;73(Supplement_1):1866-LB
https://doi.org/10.2337/db24-1866-LB
Published: 14 June 2024
View article titled, 1866-LB: A Phase 2 Study of Mazdutide 9 mg in Chinese Adults with BMI of 30 kg/m<sup>2</sup> or more
Journal Articles

Acetyllevocarnitine Hydrochloride for the Treatment of Diabetic Peripheral Neuropathy: A Phase 3 Randomized Clinical Trial in China

Lixin Guo, Qi Pan, Zhifeng Cheng, Zhiyong Li, Hongwei Jiang, Fang Zhang, Yufeng Li, Wei Qiu, Song Lu, Junhang Tian, Yanqin Fu, Fangqiong Li, Danqing Li
Journal: Diabetes
Diabetes 2024;73(5):797–805
https://doi.org/10.2337/db23-0377
Published: 06 February 2024
View article titled, Acetyllevocarnitine Hydrochloride for the Treatment of Diabetic Peripheral Neuropathy: A Phase 3 Randomized Clinical Trial in China
Open the PDF for Acetyllevocarnitine Hydrochloride for the Treatment of Diabetic Peripheral Neuropathy: A Phase 3 Randomized Clinical Trial in China in another window
Meeting Abstracts

77-LB: A Novel Glucagon-Like Peptide-1 (GLP-1R) and Glucagon (GCGR) Receptor Dual Agonist, Mazdutide (IBI362), Attenuates Hyperuricemia in Hyperuricemic Rats

HONGWEI JIANG, YANZHAO ZHANG, YAN SHUANG REN
Journal: Diabetes
Diabetes 2023;72(Supplement_1):77-LB
https://doi.org/10.2337/db23-77-LB
Published: 20 June 2023
View article titled, 77-LB: A Novel Glucagon-Like Peptide-1 (GLP-1R) and Glucagon (GCGR) Receptor Dual Agonist, Mazdutide (IBI362), Attenuates Hyperuricemia in Hyperuricemic Rats
Meeting Abstracts

55-OR: HSK7653, a Novel Ultralong-Acting DPP-4 Inhibitor, as Monotherapy in Patients With Type 2 Diabetes—A Randomized, Double-Blind, Placebo-Controlled Phase III Trial

LINONG JI, FANG BIAN, TIANRONG PAN, HONGWEI JIANG, CHENGXIA JIANG, QIAN REN
Journal: Diabetes
Diabetes 2023;72(Supplement_1):55-OR
https://doi.org/10.2337/db23-55-OR
Published: 20 June 2023
View article titled, 55-OR: HSK7653, a Novel Ultralong-Acting DPP-4 Inhibitor, as Monotherapy in Patients With Type 2 Diabetes—A Randomized, Double-Blind, Placebo-Controlled Phase III Trial
Meeting Abstracts

603-P: The Effect of Different Frequency of Autonomous Flash Glucose Monitoring Application on Blood Glucose Control in Patients with Type 1 Diabetes under 14 Years Old

KEYAN HU, HONGWEI JIANG, WINNIE ZHANG, HUIFANG PENG, JING LIU
Journal: Diabetes
Diabetes 2021;70(Supplement_1):603-P
https://doi.org/10.2337/db21-603-P
Published: 01 June 2021
View article titled, 603-P: The Effect of Different Frequency of Autonomous Flash Glucose Monitoring Application on Blood Glucose Control in Patients with Type 1 Diabetes under 14 Years Old
Meeting Abstracts

385-P: Exosomal MiR-146a-5p from Macrophages Inhibits Diabetic Nephropathy Fibrosis by Targeting Smad4

WENNING ZHANG, HONGWEI JIANG, YUJIN MA, HUIFANG PENG, JING LIU, JINGYA YUAN, KEYAN HU, BING ZHAO, HONGLI WU
Journal: Diabetes
Diabetes 2021;70(Supplement_1):385-P
https://doi.org/10.2337/db21-385-P
Published: 01 June 2021
View article titled, 385-P: Exosomal MiR-146a-5p from Macrophages Inhibits Diabetic Nephropathy Fibrosis by Targeting Smad4
Meeting Abstracts

667-P: IBI362 (LY3305677), a Weekly-Dose Glucagon-Like Peptide-1/Glucagon Receptor Dual Agonist, in Subjects with Overweight or Obesity

HONGWEI JIANG, PEI AN, HELENA DENG, LI LI, LIQI FENG, QINGYANG MA, LEI QIAN, LINONG JI
Journal: Diabetes
Diabetes 2021;70(Supplement_1):667-P
https://doi.org/10.2337/db21-667-P
Published: 01 June 2021
View article titled, 667-P: IBI362 (LY3305677), a Weekly-Dose Glucagon-Like Peptide-1/Glucagon Receptor Dual Agonist, in Subjects with Overweight or Obesity
Journal Articles

TIMP-1 Transgenic Mice Recover From Diabetes Induced by Multiple Low-Dose Streptozotocin

Hongwei Jiang, Hanyu Zhu, Xiangmei Chen, Youming Peng, Jianzhong Wang, Fuyou Liu, Suozhu Shi, Bo Fu, Yang Lu, Quan Hong, Zhe Feng, Kai Hou, Xuefeng Sun, Guangyan Cai, Xueguang Zhang, Yuansheng Xie
Journal: Diabetes
Diabetes 2007;56(1):49–56
https://doi.org/10.2337/db06-0710
Published: 01 January 2007
View article titled, TIMP-1 Transgenic Mice Recover From Diabetes Induced by Multiple Low-Dose Streptozotocin
Open the PDF for TIMP-1 Transgenic Mice Recover From Diabetes Induced by Multiple Low-Dose Streptozotocin in another window